These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33536282)

  • 1. Cardiac ryanodine receptor calcium release deficiency syndrome.
    Sun B; Yao J; Ni M; Wei J; Zhong X; Guo W; Zhang L; Wang R; Belke D; Chen YX; Lieve KVV; Broendberg AK; Roston TM; Blankoff I; Kammeraad JA; von Alvensleben JC; Lazarte J; Vallmitjana A; Bohne LJ; Rose RA; Benitez R; Hove-Madsen L; Napolitano C; Hegele RA; Fill M; Sanatani S; Wilde AAM; Roberts JD; Priori SG; Jensen HK; Chen SRW
    Sci Transl Med; 2021 Feb; 13(579):. PubMed ID: 33536282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome.
    Roston TM; Wei J; Guo W; Li Y; Zhong X; Wang R; Estillore JP; Peltenburg PJ; Noguer FRI; Till J; Eckhardt LL; Orland KM; Hamilton R; LaPage MJ; Krahn AD; Tadros R; Vinocur JM; Kallas D; Franciosi S; Roberts JD; Wilde AAM; Jensen HK; Sanatani S; Chen SRW
    JAMA Cardiol; 2022 Jan; 7(1):84-92. PubMed ID: 34730774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death.
    Zhong X; Guo W; Wei J; Tang Y; Liu Y; Zhang JZ; Tan VH; Zhang L; Wang R; Jones PP; Napolitano C; Priori SG; Chen SRW
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Phenotypic Manifestations in a Family with a Novel RYR2 E4107A Variant.
    Hasegawa H; Tamura S; Nakajima T; Kawabata-Iwakawa R; Kobari T; Matsumoto N; Sano Y; Nishiyama M; Kurabayashi M; Kaneko Y; Nakatani Y; Ishii H
    Int Heart J; 2024; 65(3):580-585. PubMed ID: 38825499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency Syndrome.
    Ormerod JOM; Ormondroyd E; Li Y; Taylor J; Wei J; Guo W; Wang R; Sarton CNS; McGuire K; Dreau HMP; Taylor JC; Ginks MR; Rajappan K; Chen SRW; Watkins H
    Circ Genom Precis Med; 2022 Feb; 15(1):e003589. PubMed ID: 34949103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular, Subcellular, and Arrhythmogenic Mechanisms in Genetic RyR2 Disease.
    Fowler ED; Zissimopoulos S
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
    Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium Release Deficiency Syndrome: A New Inherited Arrhythmia Syndrome.
    Kallas D; Roberts JD; Sanatani S; Roston TM
    Card Electrophysiol Clin; 2023 Sep; 15(3):319-329. PubMed ID: 37558302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Ca
    Ni M; Li Y; Wei J; Song Z; Wang H; Yao J; Chen YX; Belke D; Estillore JP; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Feng W; Chen J; Roston TM; Sanatani S; Lehman A; Chen SRW
    Circ Res; 2023 Jul; 133(2):177-192. PubMed ID: 37325910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.
    Lehnart SE; Wehrens XH; Laitinen PJ; Reiken SR; Deng SX; Cheng Z; Landry DW; Kontula K; Swan H; Marks AR
    Circulation; 2004 Jun; 109(25):3208-14. PubMed ID: 15197150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death.
    Thomas NL; George CH; Lai FA
    Cardiovasc Res; 2004 Oct; 64(1):52-60. PubMed ID: 15364613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
    Wangüemert F; Bosch Calero C; Pérez C; Campuzano O; Beltran-Alvarez P; Scornik FS; Iglesias A; Berne P; Allegue C; Ruiz Hernandez PM; Brugada J; Pérez GJ; Brugada R
    Heart Rhythm; 2015 Jul; 12(7):1636-43. PubMed ID: 25814417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor.
    Przybylski R; Abrams DJ
    Curr Opin Cardiol; 2023 Jul; 38(4):390-395. PubMed ID: 37016946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome.
    Hirose S; Murayama T; Tetsuo N; Hoshiai M; Kise H; Yoshinaga M; Aoki H; Fukuyama M; Wuriyanghai Y; Wada Y; Kato K; Makiyama T; Kimura T; Sakurai T; Horie M; Kurebayashi N; Ohno S
    Europace; 2022 Mar; 24(3):497-510. PubMed ID: 34661651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
    Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
    Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
    Xiong J; Liu X; Gong Y; Zhang P; Qiang S; Zhao Q; Guo R; Qian Y; Wang L; Zhu L; Wang R; Hao Z; Wen H; Zhang J; Tang K; Zang WF; Yuchi Z; Chen H; Chen SRW; Zheng W; Wang SQ; Xu YW; Liu Z
    J Mol Cell Cardiol; 2018 Apr; 117():26-35. PubMed ID: 29477366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.
    Jiang D; Xiao B; Zhang L; Chen SR
    Circ Res; 2002 Aug; 91(3):218-25. PubMed ID: 12169647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.